Skip to content
HealthTech Series A Founded 2017

Hugo Biotech

HUGO BIOTECH is a developer of cloud-based pathogenic microorganism data analysis system PACE. The device is used for image capture, visualization, and biological significance analysis. The Illumina Genetic Analyzer Pipeline software is used to perform preliminary analysis on the data to obtain conversion from image capture to intensity signal value, and then calculate to base sequence. It helps to determine the DNA…

📍 Beijing, China · Life Sciences Tech,

Funding snapshot

Last roundSeries A
Amount$32M
Date28 September 2020
Total raised$34M
Team size5

About

HUGO BIOTECH is a developer of cloud-based pathogenic microorganism data analysis system PACE. The device is used for image capture, visualization, and biological significance analysis. The Illumina Genetic Analyzer Pipeline software is used to perform preliminary analysis on the data to obtain conversion from image capture to intensity signal value, and then calculate to base sequence. It helps to determine the DNA sequence of pathogenic microorganisms in clinical samples like cerebrospinal flu Founded in 2017, headquartered in Beijing, China. The company has raised $33.5M at the Series A stage backed by investors including Chuangxin Innovation Works, CD Capital, NLVC, Sinovation Ventures, Shanghai Healthcare Capital. Operating in HealthTech > Life Sciences Tech, Life Sciences > Life Sciences Tech.

Business model

Life Sciences Tech > Research & Development > Drug Informatics > Clinical Data Analysis > Omics Analysis,

Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing

Founders & team highlights

Serial Founder

Institutional investors

Chuangxin Innovation Works CD Capital NLVC Sinovation Ventures Shanghai Healthcare Capital

Latest coverage

No articles yet.

Raising like Hugo Biotech?

Analyze your pitch deck before your next raise.

Analyze My Deck →